Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà
MedNavigator.ru - Ïîèñê è ïîäáîð ëå÷åíèÿ â Ðîññèè è çà ðóáåæîì

Âåðíóòüñÿ   Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà > Ôîðóìû âðà÷åáíûõ êîíñóëüòàöèé > Ãëàçíûå áîëåçíè > Ôîðóì äëÿ îáùåíèÿ âðà÷åé-îôòàëüìîëîãîâ

Îòâåò
 
Îïöèè òåìû Ïîèñê â ýòîé òåìå Îïöèè ïðîñìîòðà
  #181  
Ñòàðûé 03.09.2015, 05:23
Àâàòàð äëÿ Ophthalmist
Ophthalmist Ophthalmist âíå ôîðóìà
Âðà÷-îôòàëüìîëîã
      
 
Ðåãèñòðàöèÿ: 25.11.2010
Ãîðîä: Åâðîïà
Ñîîáùåíèé: 2,059
Ñêàçàë(à) ñïàñèáî: 88
Ïîáëàãîäàðèëè 504 ðàç(à) çà 472 ñîîáùåíèé
Ophthalmist ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåOphthalmist ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåOphthalmist ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåOphthalmist ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåOphthalmist ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåOphthalmist ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåOphthalmist ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåOphthalmist ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåOphthalmist ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Êîíå÷íî, ÿ î çàñâåòàõ è ôèêñàöèè.
Öèòàòà:
During my career, 2 promising therapies that were
enthusiastically endorsed and used widely by clinicians did
not prove to be efficacious after careful study: pleoptics and
the CAM visual stimulator (Clemente Clarke International,
Harlow, England). Linksz first suggested that in cases of
amblyopia with eccentric fixation one would encourage
the anatomic fovea to resume fixation superiority if one
dazzled the anatomic fovea with light while shielding the
site of eccentric fixation. Pleoptic therapy was popular and
widely used for 2 decades, but it is rarely used now
because it did not prove to be superior to standard
occlusion therapy.
Îêêëþçèþ íèêòî íå ñïèñûâàë â óòèëü, ñïàñèáî çà ïîïðàâêó.
È âèäèìî Õîéò íå ñëó÷àéíî òàê íàïèñàë, èçíà÷àëüíî ïîä ïëåîïòèêîé ïîíèìàëèñü ìàíèïóëÿöèè ñ ôèêñàöèåé:
Öèòàòà:
In the 1940s, Bangerter began systematic active therapy of amblyopia with eccentric fixation using a method for which he coined the term pleoptics
The principle of Bangerter’s method was to dazzle the eccentrically fixating retinal area with bright lights while protecting the fovea with a disk projected onto the fundus, followed by intermittent stimulation of the macula with flashes of light. This treatment is administered under direct observation of the fundus by the therapist, using a modification of the Gullstrand ophthalmoscope (pleoptophor) and is continued until the central scotoma diminishes and fixation becomes central. For use in combination with the dazzling method, Bangerter invented numerous instruments to train deficient oculomanual coordination, separation difficulties, and fusional amplitudes.
A wave of enthusiasm followed introduction of pleoptics, spreading throughout the ophthalmic literature, and numerous reports have attested to its value in treating amblyopia with central and eccentric fixation. However, it soon became apparent that pleoptic treatment should be limited to older and more cooperative children and that considerable time and effort were required before appreciable results were noted. In Europe this led to the establishment of Sehschulen ("vision schools") to which children were admitted (and readmitted) for several weeks or even months of daily therapy sessions. Eventually, studies were published that questioned the long-term effectiveness of pleoptic therapy, its superiority over conventional occlusion treatment, and its practicality from a socioeconomic point of view. The enthusiasm of most ophthalmologists and orthoptists for pleoptics has waned and, fortunately, so has the prevalence of eccentric fixation and deep amblyopia in older children for whom this method was originally designed. It is encouraging that most patients are now referred to the ophthalmologist at an age before eccentric fixation is firmly established and when conventional occlusion treatment alone is effective.

Although the practical importance of pleoptics has faded and, with some exceptions, pleoptics is no longer practiced, the principles of pleoptic treatment should not be forgotten. This method is the only one available for older amblyopic patients who lose their good eye and whose amblyopic eye does not recover vision spontaneously. Bangerter and Cüppers deserve credit for rejuvenating interest in the therapy of amblyopia, for advancing our knowledge of its pathophysiology, and for introducing new diagnostic methods.
Ïî áîëüøîìó ñ÷¸òó, çà ðóáåæîì, êàê è ó íàñ (çà èñêëþ÷åíèåì íåñêîëüêèõ ýíòóçèàñòîâ, â ò.÷. ó íàñ íà ôîðóìàõ), îñíîâíóþ (è åäèíñòâåííóþ) ðîëü îòâîäÿò îêêëþçèè. ß ãëóáîêî íå êîïàë, íî òå ñòàòüè, íà êîòîðûå ññûëàþòñÿ, ãîâîðÿ î íåýôôåêòèâíîñòè ïëåîïòèêè (çàñâåòîâ) â äîëãîñðî÷íîì ïåðèîäå - ÿ áû ïî÷èòàë. Åäèíñòâåííîå, ÷òî ò.ê. ôèêñàöèÿ, ïî êðàéíåé ìåðå ó íàñ, - íå îïðåäåëÿåòñÿ - òåðÿþòñÿ ñëó÷àè, êîãäà îáðàòíàÿ îêêëþçèÿ ìîãëà áû áûòü ÷àñòüþ áîëåå óñïåøíîãî ëå÷åíèÿ.
Îòâåòèòü ñ öèòèðîâàíèåì
  #182  
Ñòàðûé 03.09.2015, 14:25
iceloo iceloo âíå ôîðóìà
ÂÐÀ×
      
 
Ðåãèñòðàöèÿ: 26.02.2011
Ãîðîä: Ñàíêò-Ïåòåðáóðã, Ìîñêâà
Ñîîáùåíèé: 1,060
Ñêàçàë(à) ñïàñèáî: 231
Ïîáëàãîäàðèëè 454 ðàç(à) çà 438 ñîîáùåíèé
iceloo ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåiceloo ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåiceloo ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåiceloo ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåiceloo ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåiceloo ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåiceloo ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåiceloo ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåiceloo ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåiceloo ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåiceloo ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Íå äåëàþ çàñâåòû. Ôèçè÷åñêè íåò âðåìåíè. Äîøêîëüíèêàì - ÎÏÁ ïðè ìîíîëàòåðàëüíîì êîñîãëàçèè ñ ÍÖÔ. Øêîëüíèêàì - îáðàòíóþ îêêëþçèþ, ìàêóëîòåñòåð.
Ïîêà èç øêîëüíèêîâ ïðîëå÷èëñÿ òîëüêî îäèí, ôèêñàöèÿ öåíòðàëüíàÿ, ïåðåøëè íà ïðÿìóþ îêêëþçèþ.
Îòâåòèòü ñ öèòèðîâàíèåì
  #183  
Ñòàðûé 17.09.2015, 17:12
Àâàòàð äëÿ DrWORONZOff
 DrWORONZOff  DrWORONZOff âíå ôîðóìà
Îôòàëüìîëîã. Ìîäåðàòîð.
      
 
Ðåãèñòðàöèÿ: 11.09.2012
Ãîðîä: Ïåòðîçàâîäñê.
Ñîîáùåíèé: 3,210
Ñêàçàë(à) ñïàñèáî: 41
Ïîáëàãîäàðèëè 1,344 ðàç(à) çà 1,282 ñîîáùåíèé
DrWORONZOff ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDrWORONZOff ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDrWORONZOff ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDrWORONZOff ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDrWORONZOff ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDrWORONZOff ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDrWORONZOff ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Òèî́êòîâàÿ êèñëîòà (ëèïîåâàÿ êèñëîòà, àëüôà-ëèïîåâàÿ êèñëîòà, òèîêòàöèä).
Óáåäèòåëüíûõ äîêàçàòåëüñòâ ýôôåêòèâíîñòè ýòîãî ïðåïàðàòà â ëå÷åíèè äèàáåòè÷åñêîé ðåòèíîïàòèè ÿ íå íàø¸ë. Ïîèñê â ïàáìåäå [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
Âîò öèòàòà èç îòíîñèòåëüíî ñâåæåé ñòàòüè [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]

Öèòàòà:
Lipoic acid
Lipoic acid (LA), a disulfide derivative of octanoic acid, is able to alter the redox status of cells and interact with thiols and other antioxidants [52]. In addition to its antioxidant properties, LA improves the glucose uptake, a mechanism similar to insulin-stimulated glucose uptake [52]. During DR, in addition to elevated super-oxide levels, retina becomes dysfunctional due to increased pro-apoptotic protein and cytochrome c release from the mitochondria. This type of phenomenon usually leads to the increased retinal capillary cell apoptosis [53]. LA has been demonstrated to reduce:

Retinal capillary cell apoptosis;
Diabetic-induced nitrotyrosine elevation;
Mitochondrial overproduction of ROS;
Retinal mitochondrial and cytosolic ratios of NAD+ to NADH in rat DR model.
Moreover, LA has not only demonstrated its ability to reduce the VEGF levels but it also preserves the pericyte coverage of retinal capillaries, which may provide additional endothelial protection in rat DR model [54–56].
Íî âñå ññûëêè îòíîñÿò ê èññëåäîâàíèÿì íà æèâîòíûõ. Ðàíäîìèçèðîâàííûõ èñïûòàíèé ïðåïàðàòà ó ïàöèåíòîâ èìåííî ñ äèàáåòè÷åñêîé ðåòèíîïàòèåé ÿ íå íàø¸ë.
Öåëåñîîáðàçíîñòü íàçíà÷åíèÿ ëèïîåâîé/òèîêòîâîé êèñëîòû îôòàëüìîëîãàìè íàøèì ïàöèåíòàì ñ äèàáåòè÷åñêîé ðåòèíîïàòèåé îñòà¸òñÿ ïîä áîëüøèì ñîìíåíèåì.
Ïðîøó êîëëåã-ýíäîêðèíîëîãîâ ïîäåëèòüñÿ èõ ìíåíèåì íà ýòîò ñ÷¸ò. Ïðèâåòñòâóåòå ëè Âû âûïèñûâàíèå îêóëèñòàìè ýòîãî ïðåïàðàòà? Íàçíà÷àåòå ëè åãî ñàìè?
Îòâåòèòü ñ öèòèðîâàíèåì
  #184  
Ñòàðûé 17.09.2015, 17:53
Àâàòàð äëÿ Melnichenko
Melnichenko Melnichenko âíå ôîðóìà
ÂÐÀ×
      
 
Ðåãèñòðàöèÿ: 26.07.2001
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 117,239
Ñêàçàë(à) ñïàñèáî: 26
Ïîáëàãîäàðèëè 33,611 ðàç(à) çà 32,685 ñîîáùåíèé
Melnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
ß íå íàçíà÷àþ è ìåíÿ ñåãîäíÿ ïîäîáíûå íàçíà÷åíèÿ íå ðàäóþò ïðèìåíèòåëüíî ê ëèöàì ñ äèàáåòîì è ðåòèíîïàòèåé, ÿ ïðîìîë÷ó, åñëè êòî- òî íàçíà÷èò ïðè íåéðîïàòèè
__________________
Ã.À. Ìåëüíè÷åíêî
Îòâåòèòü ñ öèòèðîâàíèåì
  #185  
Ñòàðûé 17.09.2015, 18:06
Àâàòàð äëÿ DrWORONZOff
 DrWORONZOff  DrWORONZOff âíå ôîðóìà
Îôòàëüìîëîã. Ìîäåðàòîð.
      
 
Ðåãèñòðàöèÿ: 11.09.2012
Ãîðîä: Ïåòðîçàâîäñê.
Ñîîáùåíèé: 3,210
Ñêàçàë(à) ñïàñèáî: 41
Ïîáëàãîäàðèëè 1,344 ðàç(à) çà 1,282 ñîîáùåíèé
DrWORONZOff ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDrWORONZOff ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDrWORONZOff ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDrWORONZOff ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDrWORONZOff ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDrWORONZOff ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDrWORONZOff ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Ñïàñèáî.
Öèòàòà:
Ñîîáùåíèå îò Melnichenko Ïîñìîòðåòü ñîîáùåíèå
ÿ ïðîìîë÷ó, åñëè êòî- òî íàçíà÷èò ïðè íåéðîïàòèè
Äà, ïðî íåéðîïàòèþ ìíå òîæå ïîïàëîñü ïðè ïîèñêå [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
Ñ Âàøåé òî÷êè çðåíèÿ, êàêîâî âîîáùå ìåñòî äàííîãî ïðåïàðàòà ïðè âåäåíèè ïàöèåíòîâ ñ ÑÄ? Åñòü ëè îíî (ìåñòî)?
Îòâåòèòü ñ öèòèðîâàíèåì
  #186  
Ñòàðûé 17.09.2015, 18:36
Samitin Samitin âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
      
 
Ðåãèñòðàöèÿ: 27.08.2009
Ãîðîä: Ñàðàòîâ
Ñîîáùåíèé: 2,224
Ñêàçàë(à) ñïàñèáî: 8
Ïîáëàãîäàðèëè 765 ðàç(à) çà 691 ñîîáùåíèé
Samitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
 ãàéäàõ ïî áîëåâîé íåéðîïàòèè òèîêòîâàÿ êèñëîòà óïîìèíàåòñÿ êàê èìåþùàÿ â àêòèâå îäíî (êàæåòñÿ) ðàíäîìèçèðîâàííîå èññëåäîâàíèå ñ ïîëîæèòåëüíûì ðåçóëüòàòîì, ò.å. íà õîðîøèé óðîâåíü äîêàçàòåëüíîñòè çà èñòîðèþ ñóùåñòâîâàíèÿ ïðåïàðàòà äàííûõ íå íàñêðåáëè. Åñëè ìíå íå èçìåíÿåò ïàìÿòü, â îðãàíèçàöèè òîãî ïðîòîêîëà àêòèâíî ó÷àñòâîâàëè ðîññèéñêèå òîâàðèùè.
Íåêîòîðûì ïàöèåíòàì ïîìîãàåò - íî ïëàöåáíûé ëè ýòî ýôôåêò èëè íåò, ñêàçàòü íå âîçüìóñü...
Îòâåòèòü ñ öèòèðîâàíèåì
  #187  
Ñòàðûé 17.09.2015, 19:23
Àâàòàð äëÿ Melnichenko
Melnichenko Melnichenko âíå ôîðóìà
ÂÐÀ×
      
 
Ðåãèñòðàöèÿ: 26.07.2001
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 117,239
Ñêàçàë(à) ñïàñèáî: 26
Ïîáëàãîäàðèëè 33,611 ðàç(à) çà 32,685 ñîîáùåíèé
Melnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Íàñêîëüêî ïîìíþ îáñóæäåíèÿ íà ýòó òåìó -â òåõ èññëåäîâàíèÿõ ,ãäå â ÷èñëî ëèö ñ äèàáåòè÷åñêîé íåéðîïàòèåé ìîãëè çàòåñàòüñÿ ëèöà ñ àëêîãîëüíûì êîìïîíåíòîì ,íàèáîëåå õîðîøèå ðåçóëüòàòû
__________________
Ã.À. Ìåëüíè÷åíêî
Îòâåòèòü ñ öèòèðîâàíèåì
  #188  
Ñòàðûé 10.10.2015, 15:15
Àâàòàð äëÿ DrWORONZOff
 DrWORONZOff  DrWORONZOff âíå ôîðóìà
Îôòàëüìîëîã. Ìîäåðàòîð.
      
 
Ðåãèñòðàöèÿ: 11.09.2012
Ãîðîä: Ïåòðîçàâîäñê.
Ñîîáùåíèé: 3,210
Ñêàçàë(à) ñïàñèáî: 41
Ïîáëàãîäàðèëè 1,344 ðàç(à) çà 1,282 ñîîáùåíèé
DrWORONZOff ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDrWORONZOff ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDrWORONZOff ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDrWORONZOff ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDrWORONZOff ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDrWORONZOff ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDrWORONZOff ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Êîëëåãà ïîäåëèëàñü. Ãîâîðèò, ÷òî òàêîå äàæå íàçíà÷àþò ãäå-òî.
Ïîõîæå, ÷òî ýòà òåìà íåñêîí÷àåìà, êàê è êîëè÷åñòâî áðåäà, êîòîðîå òîëüêî ïðèáûâàåò â íàøó ìåäèöèíó è â îôòàëüìîëîãèþ â ÷àñòíîñòè.

Âñòðå÷àéòå, ãëàçíûå êàïëè:
-Èíôîðìàöèîííûé Ýëèêñèð äëÿ Ãëàç (ÈÝÃ)
-DreamTeam MagicEye™
-Ýíåðãî – èíôîðìàöèîííûå êàïëè

Ðå÷è î êàêèõ-òî ññûëêàõ íà èññëåäîâàíèÿ, ðàçóìååòñÿ, íå ñòîÈò. Íèêòî èõ íîðìàëüíî íå èññëåäîâàë.
Îòâåòèòü ñ öèòèðîâàíèåì
  #189  
Ñòàðûé 11.10.2015, 09:38
Àâàòàð äëÿ DrWORONZOff
 DrWORONZOff  DrWORONZOff âíå ôîðóìà
Îôòàëüìîëîã. Ìîäåðàòîð.
      
 
Ðåãèñòðàöèÿ: 11.09.2012
Ãîðîä: Ïåòðîçàâîäñê.
Ñîîáùåíèé: 3,210
Ñêàçàë(à) ñïàñèáî: 41
Ïîáëàãîäàðèëè 1,344 ðàç(à) çà 1,282 ñîîáùåíèé
DrWORONZOff ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDrWORONZOff ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDrWORONZOff ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDrWORONZOff ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDrWORONZOff ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDrWORONZOff ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDrWORONZOff ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Êîëëåãà, äîáàâèëà åù¸.
-Ýêñòðàêò Àëîý ïî Ôèëàòîâó
-Ýêñòðàêò àëîý ïî Ô¸äîðîâó

(Òàêèìè ÂÅËÈÊÈÌÈ èìåíàìè ïðèêðûâàþòñÿ))
-Ãëàçíûå êàïëè Èñîòèí.
Èç èíñòðóêöèè ê ïîñëåäíåìó. Ïîêàçàíèÿ:
Öèòàòà:
Êàòàðàêòà, ãëàóêîìà, Emblyopia, ðàííèå ñòàäèè êîñîãëàçèÿ, àòðîôèÿ çðèòåëüíîãî íåðâà, ýêçîôòàëüì, ïîòåðÿ è îñëàáëåíèå çðåíèÿ èç-çà äëèòåëüíîé ðàáîòå íà êîìïüþòåðå è ïðîñìîòðà ÒÂ, áîëüøèå äîçû àíòèáèîòèêîâ / ñòåðîèäîâ, óêóñà çìåè, Ñîëíå÷íûé ðåòèíèò, ýëåêòðè÷åñêèå / ñâàðêè èñêðåíèÿ, áîëüøèå äîçû ñïèðòíîãî, îòðàâëåíèå ãàçîì, êðåêåðàìè, ÿäîâèòûõ öâåòàìè è òï.
Òàê æå êàïëè Èñîòèí õîðîøî ïîìîãàþò îñòàíîâèòü ñíèæåíèå çðåíèÿ ïðè äèàáåòå.
Åù¸ òàêîé ïðåïàðàò êñèìåäîí êàêèì-òî îáðàçîì ïûòàþòñÿ ïðèëåïèòü ê ëå÷åíèþ íåêîòîðûõ ãëàçíûõ áîëåçíåé.
Îòâåòèòü ñ öèòèðîâàíèåì
  #190  
Ñòàðûé 26.11.2015, 17:58
Àâàòàð äëÿ DrWORONZOff
 DrWORONZOff  DrWORONZOff âíå ôîðóìà
Îôòàëüìîëîã. Ìîäåðàòîð.
      
 
Ðåãèñòðàöèÿ: 11.09.2012
Ãîðîä: Ïåòðîçàâîäñê.
Ñîîáùåíèé: 3,210
Ñêàçàë(à) ñïàñèáî: 41
Ïîáëàãîäàðèëè 1,344 ðàç(à) çà 1,282 ñîîáùåíèé
DrWORONZOff ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDrWORONZOff ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDrWORONZOff ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDrWORONZOff ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDrWORONZOff ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDrWORONZOff ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDrWORONZOff ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Triphala guggul (Òðèôàëà ãóããóë) òàáëåòêè ïðèíåñëà ìíå ñåãîäíÿ îäíà ïàöèåíòêà, ÷òîáû ïîñîâåòîâàòüñÿ îá èõ ýôôåêòèâíîñòè è áåçîïàñíîñòè.
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
Íåò êëèíè÷åñêèõ èñïûòàíèé, íåò êîììåíòàðèåâ â ïîëüçó ýòèõ ïðåïàðàòîâ.
Ðåêîìåíäîâàíî íå ïðèíèìàòü.
Îòâåòèòü ñ öèòèðîâàíèåì
  #191  
Ñòàðûé 29.11.2015, 01:26
Àâàòàð äëÿ Dimka_Krasnov
Dimka_Krasnov Dimka_Krasnov âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
 
Ðåãèñòðàöèÿ: 27.11.2015
Ãîðîä: Ñàìàðà
Ñîîáùåíèé: 1
Ñêàçàë(à) ñïàñèáî: 1
Dimka_Krasnov *
íàôòèäðîôóðèë ïðè ÂÌÄ, ãëàóêîìå, äèàáåòå, âåíîçíîì òðîìáîçå
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]

Êîêðàíîâñêèõ îáçîðîâ îòíîñèòåëüíî ãëàç íåò
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]

ïðî ãëàóêîìó
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]

ïðî äèàáåò
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]

Êîììåíòàðèè ê ñîîáùåíèþ:
DrWORONZOff îäîáðèë(à): Ñïàñèáî. Òîëüêî ðåçóëüòàòû èññëåäîâàíèé íà æèâîòíûõ - î÷åíü íèçêèé óðîâåíü äîêàçàòåëüíîñòè.
Îòâåòèòü ñ öèòèðîâàíèåì
  #192  
Ñòàðûé 29.11.2015, 20:42
Àâàòàð äëÿ Flixxxer
Flixxxer Flixxxer âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
 
Ðåãèñòðàöèÿ: 21.10.2014
Ãîðîä: Ñàíêò-Ïåòåðáóðã
Ñîîáùåíèé: 53
Ñêàçàë(à) ñïàñèáî: 4
Ïîáëàãîäàðèëè 26 ðàç(à) çà 25 ñîîáùåíèé
Flixxxer ýòîò ó÷àñòíèê èìååò îòëè÷íóþ ðåïóòàöèþ íà ôîðóìå
èç òîé æå ñåðèè, ÷òî è íåéðîïðîòåêöèÿ ïðè íîðìîòåíçèâíîé ãëàóêîìå. ÷óøü.
Îòâåòèòü ñ öèòèðîâàíèåì
  #193  
Ñòàðûé 16.01.2016, 12:17
Àâàòàð äëÿ DrWORONZOff
 DrWORONZOff  DrWORONZOff âíå ôîðóìà
Îôòàëüìîëîã. Ìîäåðàòîð.
      
 
Ðåãèñòðàöèÿ: 11.09.2012
Ãîðîä: Ïåòðîçàâîäñê.
Ñîîáùåíèé: 3,210
Ñêàçàë(à) ñïàñèáî: 41
Ïîáëàãîäàðèëè 1,344 ðàç(à) çà 1,282 ñîîáùåíèé
DrWORONZOff ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDrWORONZOff ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDrWORONZOff ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDrWORONZOff ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDrWORONZOff ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDrWORONZOff ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDrWORONZOff ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Àïïàðàò "Âèòàôîí".
Îñòîðîæíî! Íåäîáðîïîðÿäî÷íûå ëþäè ñî ñâîèìè àïïàðàòàìè äîáðàëèñü è äî îôòàëüìîëîãèè. Ýôôåêòèâíîñòü è áåçîïàñíîñòü ïðèáîðà íå äîêàçàíû â êëèíè÷åñêèõ èññëåäîâàíèÿõ.
Îòâåòèòü ñ öèòèðîâàíèåì
  #194  
Ñòàðûé 16.01.2016, 13:02
Àâàòàð äëÿ DrWORONZOff
 DrWORONZOff  DrWORONZOff âíå ôîðóìà
Îôòàëüìîëîã. Ìîäåðàòîð.
      
 
Ðåãèñòðàöèÿ: 11.09.2012
Ãîðîä: Ïåòðîçàâîäñê.
Ñîîáùåíèé: 3,210
Ñêàçàë(à) ñïàñèáî: 41
Ïîáëàãîäàðèëè 1,344 ðàç(à) çà 1,282 ñîîáùåíèé
DrWORONZOff ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDrWORONZOff ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDrWORONZOff ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDrWORONZOff ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDrWORONZOff ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDrWORONZOff ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDrWORONZOff ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Ãëàçíûå êàïëè "Îêàïèí" - òàê íàçûâàåìûé âèòàìèíèçèðîâàííûé òîíèê Îêàïèí. Ñðåäñòâà ñ òàêèì íàçâàíèåì â ãîñóäàðñòâåííûõ ðååñòðàõ ñåðòèôèêàöèè ÁÀÄîâ è ëå÷åáíûõ ïðîäóêòîâ íåò.
Îòâåòèòü ñ öèòèðîâàíèåì
  #195  
Ñòàðûé 20.01.2016, 13:41
Àâàòàð äëÿ DrWORONZOff
 DrWORONZOff  DrWORONZOff âíå ôîðóìà
Îôòàëüìîëîã. Ìîäåðàòîð.
      
 
Ðåãèñòðàöèÿ: 11.09.2012
Ãîðîä: Ïåòðîçàâîäñê.
Ñîîáùåíèé: 3,210
Ñêàçàë(à) ñïàñèáî: 41
Ïîáëàãîäàðèëè 1,344 ðàç(à) çà 1,282 ñîîáùåíèé
DrWORONZOff ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDrWORONZOff ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDrWORONZOff ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDrWORONZOff ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDrWORONZOff ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDrWORONZOff ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDrWORONZOff ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Àïïàðàò "Âèðòóñ" - î÷åðåäíîå äåòèùå øàðëàòàíîâ.
Âíèìàíèå! Îïàñíàÿ ðåêëàìà! Öèòèðóþ:
Öèòàòà:
Êàòàðàêòà", "ãëàóêîìà", "îòñëîåíèå ñåò÷àòêè" - òåïåðü ëèøü ñòðàøíûå ñëîâà.
Ñî÷åòàíèå òàêèõ ñëîâ êàê ãëàóêîìà è êàòàðàêòà íàèáîëåå ÷àñòî èñïîëüçóåòñÿ äëÿ ðåêëàìèðîâàíèÿ øàðëàòàíñêèõ ñíàäîáèé è ïðèáîðîâ.
Íèêàêîé ïðèáîð íå ìîæåò îäíîâðåìåííî ëå÷èòü êàòàðàêòó, ãëàóêîìó è îòñëîéêó ñåò÷àòêè äàæå, åñëè îí ðåêîìåíäîâàí ïðîôåññîðîì îôòàëüìîëîãèè.
Îòâåòèòü ñ öèòèðîâàíèåì
Îòâåò



Âàøè ïðàâà â ðàçäåëå
Âû íå ìîæåòå ñîçäàâàòü òåìû
Âû íå ìîæåòå îòâå÷àòü íà ñîîáùåíèÿ
Âû íå ìîæåòå ïðèêðåïëÿòü ôàéëû
Âû íå ìîæåòå ðåäàêòèðîâàòü ñîîáùåíèÿ

BB êîäû Âêë.
Ñìàéëû Âêë.
[IMG] êîä Âêë.
HTML êîä Âûêë.



×àñîâîé ïîÿñ GMT +3, âðåìÿ: 10:50.




Ðàáîòàåò íà vBulletin® âåðñèÿ 3.
Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.